P-238Phase 3 (COSMIC-312) study of cabozantinib in combination with atezolizumab vs sorafenib in patients with advanced hepatocellular carcinoma (aHCC) who have not received previous systemic anticancer therapy. (2nd July 2019)

Record Type:: Journal Article
Title:: P-238Phase 3 (COSMIC-312) study of cabozantinib in combination with atezolizumab vs sorafenib in patients with advanced hepatocellular carcinoma (aHCC) who have not received previous systemic anticancer therapy. (2nd July 2019)
Main Title:: P-238Phase 3 (COSMIC-312) study of cabozantinib in combination with atezolizumab vs sorafenib in patients with advanced hepatocellular carcinoma (aHCC) who have not received previous systemic anticancer therapy
Authors:: Rimassa, L
Cheng, A
Braiteh, F
Benzaghou, F
Hazra, S
Borgman, A
Sinha, R
Kayali, Z
Zhu, A
Kelley, R
Abstract:
Is Part Of:: Annals of oncology. Volume 30(2019)Supplement 4
Journal:: Annals of oncology
Issue:: Volume 30(2019)Supplement 4
Issue Display:: Volume 30, Issue 4 (2019)
Year:: 2019
Volume:: 30
Issue:: 4
Issue Sort Value:: 2019-0030-0004-0000
Page Start:
Page End:
Publication Date:: 2019-07-02
Subjects:: Oncology -- Periodicals
616.992
Journal URLs:: https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:: 10.1093/annonc/mdz155.237 ↗
Languages:: English
ISSNs:: 0923-7534
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 12137.xml